In The NewsView All
Regenstrief Research Scientist Alexia M. Torke, M.D., M.S., described how chaplain support care for family members in charge of making tough decisions for their loved ones in the ICU can help improve their overall mental health.Read More
‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia
Regenstrief Institute Research Scientist NiCole Keith, PhD, addressed the many...Read More
Featured FellowshipView all
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
NewsFactors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research
NewsMulti-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance
Quality of health, quality of life
There is so much more to treating a patient than simply managing the primary effects of an illness. Many diseases and conditions have associated symptoms which can diminish a person’s quality of life, such as chronic pain, fatigue, insomnia, or depression. Sometimes these symptoms are treatment-related, such as the pain, nausea, or cognitive impairment that can occur in cancer patients undergoing chemotherapy.
From biology to behavior, medicine to mindfulness, Regenstrief looks at ways to reduce and manage adverse symptoms and improve the lives of those with long or short-term illnesses.
Related News & Stories
Study identifies four distinct pain trajectories in nursing home residents
New understanding of pain over time may alter care and improve quality of life Despite awareness that pain is common in nursing home residents, there has...
Study one of first to compare pain relief options for chronic low back pain patients already on opioids
To help patients manage chronic, often debilitating pain, physicians frequently prescribe medications as first line therapy, although treatment guidelines often call for non-pharmacologic approaches. One of...
Dr. Shelley Johns on breast cancer survivor-supporting study
Regenstrief research scientist, Shelley Johns, PsyD, discusses the FACing FEAR study, which assists breast cancer survivors with fear of recurrence.
Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms
Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental disorder A recent study from Indiana University...
COOPERATE: Regenstrief and VA Research Scientists addressing health disparity at the patient level
One of first studies focused on empowering Black veterans who have chronic back and other musculoskeletal pain Black patients have historically faced disparities in pain treatment,...
How older adults and their caregivers view pain, depression and other patient symptoms
Patients and proxies more likely to agree on the physical than the psychological Adults, especially older adults, may be in pain or depressed but not able...
Depression detection has never been more important: PHQ-9 enables clinicians and patients to track and address depression with combined physical and emotional symptoms score
Large, international study shows free, clinical measurement tool definitively indicates presence and severity of the disorder The COVID-19 pandemic, armed conflicts, economic dislocations and other concerns...
Study explores perceptions of and preferences for complementary and integrative medicine options for chronic headache
A new study from researchers with the U.S. Department of Veterans Affairs and the Regenstrief Institute is one of the first to explore the perceptions and...
More than just resiliency training: Organizations need to address causes of burnout
Study identifies three major areas to reduce burnout and increase work engagement Clinician burnout in healthcare is a growing area of concern, especially as the COVID-19...
Newer depression screeners successfully measure symptoms and follow progress of treatment
Screening especially important in light of COVID-19 pandemic Depression is the second most disabling condition in the world, after pain, so screening and diagnosis are crucial...
Regenstrief research scientist mentors team developing mania tracking screener
Scientists, including Regenstrief research scientist Kurt Kroenke, M.D., have developed a questionnaire to help assess symptoms of manic episodes in patients.
Algorithm developed by Regenstrief/Merck collaboration hailed as promising research tool
A natural language processing (NLP) algorithm to identify patients with chronic cough, created and validated by Regenstrief Institute, Indiana University and Merck & Co. research scientists, is being recognized for its ingenuity...
Collaborative care effective for pain, depression and anxiety
Provides patients with symptom-based conditions with support between physician visits With the growing prevalence of chronic pain, depression, anxiety, and other symptom-based conditions, physicians and the...
Brief survey tool tracks symptoms, aids in evaluating effectiveness of treatment
Shorter version alleviates response burden and saves time Researchers from Regenstrief Institute and Indiana University School of Medicine have developed and validated a short questionnaire to help patients report...
Utilizing telecare to motivate depressed individuals who take opioids into treatment
Regenstrief and IU evaluate tool to help primary care physicians counter opioid epidemic Drawing upon their experience and expertise in telehealth, collaborative care models, substance use...
Acceptance and commitment therapy may ease fear of recurrence in cancer survivors
Acceptance and commitment therapy (ACT) shows promise for treating fear of cancer recurrence in women who have survived breast cancer. The first of its kind study...
Regenstrief researcher gives perspective on reminiscence therapy
“It really focuses on maintaining the dignity of people with dementia,” Dr. Bateman tells U.S. News and World Report Regenstrief researcher Daniel Bateman, M.D., is intrigued...
Regenstrief and VA researcher receives $21 million grant for national study of chronic low back pain management
Matthew J. Bair, M.D., M.S., a research scientist with the Regenstrief Institute and the U.S. Department of Veterans Affairs, will co-lead a $21 million national study...
Combined online self-management for pain, associated anxiety and depression works
Online self-management helps; for some the online system plus nurse telecare helps more Pain is the most common physical symptom for which adults seek medical attention...
Tracking Symptoms: New Regenstrief and IU Tool Helps Providers Identify Underlying Causes
SymTrak advances clinicians toward next generation of population health management. An easy to use, brief, inexpensive new tool developed and validated by researchers at the Regenstrief...
Regenstrief expert in symptoms and pain receives Society of General Internal Medicine’s highest award
INDIANAPOLIS – Kurt Kroenke, MD, a Regenstrief Institute investigator and the director of the institute’s education and training programs, has been named the recipient of the...